IMU 1.82% 5.6¢ imugene limited

aust leads world in h5n1, page-2

  1. 4,996 Posts.
    Our lead product, the Poultry productivity enhancer, has now completed all pre-regulatory trials with growth and feed conversion results that have far exceeded earlier trials. This latest trial has confirmed dosage, timing and method of administration. Accordingly, this product is now ready for the regulatory trials and commercialisation. Our latest trials showed results of 13% weight gain. This is an outstanding result. We have not seen any existing antibiotic product or any alternative technology that has come close to this. We have begun establishing the masterseed for this product in Australia. All regulatory trials must use product from this masterseed. Our first regulatory trial will occur immediately following approval from the Office of the Gene Technology Regulator, which we hope will be granted early next year.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
0.001(1.82%)
Mkt cap ! $411.5M
Open High Low Value Volume
5.5¢ 5.7¢ 5.3¢ $731.7K 13.32M

Buyers (Bids)

No. Vol. Price($)
5 580359 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 686331 5
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.